Whole Genome Sequencing Market To Reach $6.67 Billion By 2030

Whole Genome Sequencing Market Growth & Trends

The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 22.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising adoption of whole genome sequencing for genome mapping programs and the increasing prevalence of inherited disorders, including rare genetic disorders. According to the study published in the New England Journal of Medicine in November 2021, whole genome sequencing could lead to the early diagnosis of a wide range of rare diseases and a reported transition to precision medicine.

Furthermore, the growing investment in R&D for the early detection and treatment of disorders with the aid of WGS is expected to propel the growth of the market. For instance, in February 2023, the government of Indonesia and the Genome Science Initiative, with the aid of a USD 30 million investment from the Global Fund, established a network of facilities to perform the method for the early detection and treatment of disorders, including COVID-19, tuberculosis, cancer, genetic disorders, brain diseases, and metabolic disorders.

Whole genome sequencing has a wide range of applications, and government bodies are adopting these technologies for sequencing the genomes of humans, plant, animal, and microbes, which is expected to drive market growth. For instance, U.S. Food & Drug Administration (FDA) adopted the method to identify foodborne pathogens during foodborne disease outbreaks across the countries. The FDA has adopted this technology since 2008 under the Whole Genome Sequencing (WGS) program as it enables it to distinguish all strains of foodborne pathogens more efficiently than pulse-field gel electrophoresis (PFGE).

The rising technological advancements have led to the launch of innovative whole genome sequencing products that offer an affordable, accurate, and timely diagnosis of various diseases and infections. This is contributing to the growth of the market. For instance, in December 2022, LifeCell International Pvt. Ltd. collaborated with HaystackAnalytics to launch TB, a whole genome sequencing test to identify the diagnostic information on tuberculosis infections and tackle the drug resistance challenge.

The COVID-19 pandemic led to an increased demand for the method globally, which enabled the rapid identification of SARS-CoV-2 and the development of possible diagnostic tests to manage the outbreak. Hence, governments across the globe collaborated with research organizations and the corporate sector to use the method to identify and diagnose SARS-CoV-2. Several companies have launched genomic services and rapid solutions for the surveillance of the SARS-CoV-2 virus. For instance, QIAGEN offers the whole genome sequencing services SARS-CoV-2 surveillance for the identification of potent mutants, tracing of possible outbreaks, and advancement of vaccine research and drug development.

 Request a free sample copy or view report summary: Whole Genome Sequencing Market Report

Whole Genome Sequencing Market Report Highlights

• Consumables segment held the largest share of 61.56% in 2024, owing to the availability of a wide range of consumables and increased adoption of these products due to the shorter duration of use of these products

• By type, the large whole genome sequencing segment accounted for the largest share of 77.32% in the whole genome sequencing market in 2024. This can be attributed to the growing applications for analyzing cancerous tumors and identifying genetic variations in rare diseases

• By workflow, the sequencing segment held the largest market share of 52.12% in 2024, owing to the growing involvement of major companies and the launch of novel products to boost the adoption of the process

• By application, the human whole genome sequencing segment dominated the market in 2024 with a share of 62.91%. This can be attributed to the growing prevalence of rare inherited disorders and growing investment in R&D for the method to identify possible causative agents of these disorders

• By end-use, the academic & research institutes segment dominated the global market with the largest share of 48.72%. The large share of the segment can be attributed to the growing demand for high-throughput technologies at these facilities to conduct comprehensive research in this field

• North America held the largest market share of 51.34% in 2024. The large share can be attributed to the presence of a well-established healthcare system and pharmaceutical industry in the region, which has created a significant demand for whole genome sequencing for clinical and research purposes

Whole Genome Sequencing Market Segmentation

Grand View Research has segmented the global whole genome sequencing market report based on product & service, type, workflow, application, end-use, and region:

Whole Genome Sequencing Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Consumables

• Services

Whole Genome Sequencing Type Outlook (Revenue, USD Million, 2018 - 2030)

• Large Whole Genome Sequencing

• Small Whole Genome Sequencing

Whole Genome Sequencing Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Pre-sequencing

• Sequencing

• Data Analysis

Whole Genome Sequencing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Human Whole Genome Sequencing

• Plant Whole Genome Sequencing

• Animal Whole Genome Sequencing

• Microbial Whole Genome Sequencing

Whole Genome Sequencing End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Academic & Research Institutes

• Hospitals & Clinics

• Pharmaceutical & Biotechnology Companies

• Others

Whole Genome Sequencing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Whole Genome Sequencing Market

• Illumina, Inc.

• Thermo Fisher Scientific, Inc.

• Oxford Nanopore Technologies

• Pacific Biosciences of California, Inc.

• BGI

• QIAGEN

• Agilent Technologies

• ProPhase Labs, Inc. (Nebula Genomics)

• Psomagen

• Azenta US, Inc. (GENEWIZ)